The 15th Cancer Crosslinks presented on
Thursday, January 26, 2023
New dimensions to the hallmarks of cancer: How is the last decade of discoveries advancing our understanding of cancer biology and transforming precision medicine?
This event included a daytime educational program followed by a
special 15th Cancer Crosslinks afternoon networking session.
Cancer Crosslinks 2023 included distinguished international experts who addressed recent progress in the understanding of tumor evolution and emerging diagnostic and treatment options for solid and hematological cancers. An overview of the program is available on this page.
This event included a daytime educational program followed by a
special 15th Cancer Crosslinks afternoon networking session.
Cancer Crosslinks 2023 included distinguished international experts who addressed recent progress in the understanding of tumor evolution and emerging diagnostic and treatment options for solid and hematological cancers. An overview of the program is available on this page.
Event 2023 - International Speakers
Douglas Hanahan, Distinguished Scholar, Ludwig Institute for Cancer Research (Zurich/New York), Professor of Molecular Oncology, Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, Switzerland (digital talk)
Mariam Jamal-Hanjani, Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute; Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology, UCL Hospital, London, UK (Presented during Cancer Crosslinks 2022)
Nilofer Azad, Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (digital talk)
Alpaslan (Aslan) Tasdogan, Associate Professor, German Cancer Consortium (DKTK), Institute for Tumor Metabolism, Department of Dermatology, University Hospital Essen, Germany
Thomas Nerreter, Junior Group Leader, Chair of Cellular Immunotherapy, Translational CAR-T Research Program, University Hospital and CCC Würzburg, Germany
Tom Erkers, Assistant Professor, Karolinska Institute, Stockholm Sweden
Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Germany
Event 2023 - Topics
The Hallmarks of Cancer: New Dimensions - Integrating Pre-Clinical and Clinical Cancer Trials of Mechanism-Targeted Therapies (digital talk)
Douglas Hanahan, Distinguished Scholar, Ludwig Institute for Cancer Research (Zurich/New York), Professor of Molecular Oncology, Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, Switzerland (digital talk)
Douglas Hanahan, Distinguished Scholar, Ludwig Institute for Cancer Research (Zurich/New York), Professor of Molecular Oncology, Swiss Institute for Experimental Cancer Research, Swiss Federal Institute of Technology Lausanne, Switzerland (digital talk)
The natural history of non-small cell lung cancer evolution in TARCERTx
Mariam Jamal-Hanjani, Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute; Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology, UCL Hospital, London, UK
Mariam Jamal-Hanjani, Group Leader, Cancer Metastasis Lab, CRUK Lung Cancer Centre of Excellence, UCL Cancer Institute; Senior Clinical Lecturer and Honorary Consultant in Translational Lung Oncology, UCL Hospital, London, UK
Epigenetic (Combination) Therapy – exploiting complex biology to offer novel treatment options for patients with GI cancers
Nilofer Azad, Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (digital talk)
Nilofer Azad, Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA (digital talk)
The metabolic regulation of cancer progression
Alpaslan (Aslan) Tasdogan, Associate Professor, German Cancer Consortium (DKTK), Institute for Tumor Metabolism, Department of Dermatology, University Hospital Essen, Germany
Alpaslan (Aslan) Tasdogan, Associate Professor, German Cancer Consortium (DKTK), Institute for Tumor Metabolism, Department of Dermatology, University Hospital Essen, Germany
Cellular Therapy for solid and hematological tumors: novel targets and technologies
Thomas Nerreter, Junior Group Leader, Chair of Cellular Immunotherapy, Translational CAR-T Research Program, University Hospital and CCC Würzburg, Germany
Thomas Nerreter, Junior Group Leader, Chair of Cellular Immunotherapy, Translational CAR-T Research Program, University Hospital and CCC Würzburg, Germany
Data-driven hallmarks of acute myeloid leukemia: biological, prognostic & therapeutic implications
Tom Erkers, Assistant Professor, Karolinska Institute, Stockholm Sweden
Tom Erkers, Assistant Professor, Karolinska Institute, Stockholm Sweden
AI biomarkers in cancer: recent progress and the way to clinical implementation
Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Germany
Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence, Else Kroener Fresenius Center for Digital Health, Technical University Dresden, Germany
Event 2023 - Moderators from Norway
Moderators:
Katarina Puco, Senior Consultant Oncologist, Oslo University Hospital, Institute of Cancer Research and Lovisenberg Diaconal Hospital, Oslo
Eli Sihn Samdal Steinskog, Consultant Oncologist, Department of Oncology, Haukeland University Hospital, Bergen, Norway
Anna Pasetto, Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo; Director of the Center for Advanced Cell Therapy (ACT), Cancer Clinic, Oslo University Hospital
May-Britt Tessem, Associate Professor/Research Scientist, Department of Circulation and Medical Imaging, Faculty of Medicine and Health Services, Norwegian University of Science and Technology (NTNU)
Event 2023 - Travel Voucher
A limited number of travel vouchers are available for clinicians and healthcare personnel based in Norway (domestic travel, first come, first served). To inquire, please contact
Charlotte Homme, Head of Membership & Events, [email protected]
Event 2023 - Reference Materials
Katarina Puco, Senior Consultant Oncologist, Oslo University Hospital, Institute of Cancer Research and Lovisenberg Diaconal Hospital, Oslo
Eli Sihn Samdal Steinskog, Consultant Oncologist, Department of Oncology, Haukeland University Hospital, Bergen, Norway
Anna Pasetto, Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo; Director of the Center for Advanced Cell Therapy (ACT), Cancer Clinic, Oslo University Hospital
May-Britt Tessem, Associate Professor/Research Scientist, Department of Circulation and Medical Imaging, Faculty of Medicine and Health Services, Norwegian University of Science and Technology (NTNU)
Event 2023 - Travel Voucher
A limited number of travel vouchers are available for clinicians and healthcare personnel based in Norway (domestic travel, first come, first served). To inquire, please contact
Charlotte Homme, Head of Membership & Events, [email protected]
Event 2023 - Reference Materials
|
Organizer
|
Sponsors 2023
|
|
|
|
To learn more about previous Cancer Crosslinks events, visit the GALLERY.